Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-04-27

Clinical Trial Update: A Phase 3 Trial Comparing TACE and TARE in Unilobar Advanced Hepatocellular Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing transarterial chemoembolization (TACE) and transarterial radioembolization (TARE) for unilobar advanced hepatocellular carcinoma has b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Seoul National University Hospital | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: WITHDRAWN